ARTICLE | Company News
ExperGen, Thallion cancer news
June 21, 2010 7:00 AM UTC
Thallion said the International Chamber of Commerce International Court of Arbitration ruled in favor of ExperGen in a dispute between the companies over a 2006 deal in which Thallion licensed TLN-232...